Recombinant adeno-associated viral (AAV) vectors have been successfully employed as the mode of gene delivery in several clinical trials for the treatment of inherited retinal diseases to date. The design of such vectors is critical in determining cellular tropism and level of subsequent gene expression that may be achieved following viral delivery. Here we describe a system for living retinal tissue extraction, ex vivo culture, viral transduction and assessment of transgene expression that may be used to assess viral constructs for gene therapy in the human retina at a preclinical stage.
CITATION STYLE
Orlans, H. O., Edwards, T. L., De Silva, S. R., Patrício, M. I., & MacLaren, R. E. (2018). Human retinal explant culture for ex vivo validation of AAV gene therapy. In Methods in Molecular Biology (Vol. 1715, pp. 289–303). Humana Press Inc. https://doi.org/10.1007/978-1-4939-7522-8_21
Mendeley helps you to discover research relevant for your work.